Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company
advancing personalized medicine in cardiology, oncology, and inherited
diseases through advanced diagnostic tests and clinical and research
services, today announced that senior management will participate in the
BTIG Emerging Technologies in Healthcare Diagnostics conference.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.